logo-loader
viewe-Therapeutics plc

Riccardo Lowi on e-Therapeutics PLC

Riccardo Lowi, analyst at Capital Network talks through e-therapeutics' FY 2018 results showing good progress on the main research programs.

Quick facts: e-Therapeutics plc

Price: 2.45 GBX

AIM:ETX
Market: AIM
Market Cap: £6.59 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of e-Therapeutics plc named herein, including the promotion by the Company of e-Therapeutics plc in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

e-Therapeutics continuing to convert business development into cash...

e-Therapeutics PLC's (LON:ETX) Ray Barlow says they're actively engaged in exploring all organic and non-organic opportunities that have the potential to create incremental value for its shareholders. He adds that multiple proposals for its artificial intelligence-based drug research products...

1 week, 4 days ago

2 min read